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Setting Priorities in Global Child Health Research Investments: 
Addressing Values of Stakeholders
Aim To identify main groups of stakeholders in the process of health 
research priority setting and propose strategies for addressing their sys-
tems of values.
Methods In three separate exercises that took place between March 
and June 2006 we interviewed three different groups of stakeholders: 
1) members of the global research priority setting network; 2) a diverse 
group of national-level stakeholders from South Africa; and 3) partici-
pants at the conference related to international child health held in 
Washington, DC, USA. Each of the groups was administered different 
version of the questionnaire in which they were asked to set weights to 
criteria (and also minimum required thresholds, where applicable) that 
were a priori defined as relevant to health research priority setting by 
the consultants of the Child Health and Nutrition Research initiative 
(CHNRI).
Results At the global level, the wide and diverse group of respondents 
placed the greatest importance (weight) to the criterion of maximum 
potential for disease burden reduction, while the most stringent 
threshold was placed on the criterion of answerability in an ethical 
way. Among the stakeholders’ representatives attending the interna-
tional conference, the criterion of deliverability, answerability, and 
sustainability of health research results was proposed as the most im-
portant one. At the national level in South Africa, the greatest weight 
was placed on the criterion addressing the predicted impact on equity 
of the proposed health research.
Conclusions Involving a large group of stakeholders when setting pri-
orities in health research investments is important because the criteria 
of relevance to scientists and technical experts, whose knowledge and 
technical expertise is usually central to the process, may not be appro-
priate to specific contexts and in accordance with the views and values 
of those who invest in health research, those who benefit from it, or 
wider society as a whole.
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When decisions on investments in health re-
search are made, the term “stakeholders” re-
fers to all individuals and/or groups who have 
interest in prioritization of those investments. 
The stakeholders will therefore comprise a 
large and highly heterogeneous group. Some 
apparent examples may include research fund-
ing agencies (eg, governmental agencies, pri-
vate organizations, public-private partnerships, 
international and regional organizations, and 
taxpayers of a certain region), direct recipients 
of the funding (eg, researchers and research in-
stitutions), beneficiaries of the research (eg, 
policy makers and the general population of 
a country), and any other group with interest 
in prioritization process (eg, advocacy groups, 
journalists and media, lawyers, economists, ex-
perts in ethics, and many others).
Two fundamental characteristics of any ac-
ceptable and successful priority setting pro-
cess are legitimacy and fairness (1). In order to 
ensure the legitimacy and fairness of the pri-
ority setting decisions in health research in-
vestments, involvement of a wide range of 
stakeholders (and/or eliciting their values) is 
needed. Unfortunately, health research prior-
ities are presently mainly driven by technical 
experts (2-5). The results of prioritization are 
therefore in danger of being mostly influenced 
by their personal views, with minimal input 
from representatives from the wider communi-
ty who also may have interest in the process but 
lack the technical expertise. Since the values 
and criteria important to scientists and techni-
cal experts may vary remarkably from those of 
other relevant stakeholders (6-8), the relevance 
of eliciting wider stakeholders’ input is increas-
ingly being acknowledged (9-11). However, the 
main challenge is to develop a systematic, flexi-
ble, and repeatable strategy on how this can be 
achieved in different contexts.
The literature on priority setting for health 
interventions identifies two main strategies: 
1) stakeholders’ values may impact decisions 
through procedural processes (by having ac-
cess to the decisions and the rationales be-
hind the decisions, and by having the author-
ity to deliberate on the decisions and influence 
the final outcome); 2) stakeholders’ values can 
be directly elicited using quantitative meth-
ods (through surveys where respondents rank, 
weigh, or rate their values) and qualitative 
methods (involving individual interviews, Del-
phi technique, complaints procedures or group 
discussions, concept mapping, citizen’s jury, 
and public meetings) (12). The main challeng-
es in those attempts have mainly been the lack 
of capacity for some stakeholders to engage 
in meaningful deliberations (13) and how to 
practically incorporate the elicited stakehold-
ers’ values in decision-making (12,14). This 
paper presents our suggestions and experiences 
on how the values and interests of large and di-
verse group of stakeholders could still be incor-
porated in decisions on health research invest-
ment priorities. We specified thresholds and 
weights needed to address stakeholders’ values 
within CHNRI methodology using three dif-
ferent versions of a questionnaire. We aimed 
to assess stakeholders’ values for priority set-
ting in global health research investments. We 
tested questionnaires that presented differ-
ent levels of complexity and detail of the ques-
tions that stakeholders’ representatives would 
be asked. We also aimed to evaluate different 
strategies of turning their responses into nu-
merical thresholds and weights.
Materials and methods
Systematic methodology for setting priorities in 
health research investments
Child Health and Nutrition Research Ini-
tiative (CHNRI) has recently presented the 
main concepts underlying systematic method-
ology for setting priorities in health research 
investments (9-11). It is a flexible method-
ology that first defines all criteria relevant to 
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priority setting in a given context. In the sec-
ond step, technical experts are responsible for 
systematic listing of research options and for 
scoring all those options against all the defined 
criteria using simple and discriminative set of 
questions. This eventually leads to all research 
options receiving several different intermedi-
ate scores, each addressing one important cri-
terion relevant to priority setting. These inter-
mediate scores could, for example, address the 
criteria of answerability of research options in 
ethical way, efficacy and effectiveness of result-
ing interventions, deliverability, affordability, 
and sustainability of resulting interventions, 
maximum potential for disease burden reduc-
tion, and predicted impact on equity (9-11). 
The final research priority score, which de-
scribes the overall value of each research op-
tion when all criteria are taken into account, 
is then computed as the average of the inter-
mediate scores. Research priority score then 
becomes a basis for ranking the competing re-
search options and for combining their value 
with their proposed cost to achieve an opti-
mal mix of investments within a fixed funding 
budget. Up to this point, priority setting pro-
cess is based on profound understanding and 
knowledge of technical details and scientific 
literature. Hence, it is not proposed to involve 
non-technical stakeholders in the computa-
tion of these intermediate scores.
Strategies within CHNRI’s methodology for 
addressing stakeholders’ values
Intermediate scores assigned to each research 
option during the process described above can 
still be modified to include the values of non-
technical groups of stakeholders before the fi-
nal research priority score is computed. The 
wider group of stakeholders may: 1) define 
minimal threshold for each intermediate score 
that needs to be achieved to consider any re-
search option a funding priority; 2) allocate 
weights to intermediate scores so that the final 
research priority score is not their simple arith-
metic mean, but rather a weighted mean that 
reflects relative values assigned to each criteri-
on. In this way, some intermediate scores (pri-
ority setting criteria) would influence the val-
ue of the final score more than the others. The 
concept of introducing thresholds prevents in-
vestments into research options that dramati-
cally fail one of the important criteria, regard-
less how well they fare when scored against 
other criteria. The concept of weights is graph-
ically presented in Figure 1.
The concept of pre-defined thresholds on 
each of the criteria prevents funding of pro-
posed research option if it largely fails one im-
portant criterion, regardless how well it com-
plies with all other criteria. In the first exercise 
presented in the results section, stakehold-
ers’ representatives were asked to draw a hori-
zontal line on a vertical bar ranging between 
0 and 100 (as in Figure 1) to define where 
they would like to see minimum thresholds 
for compliance with each of the relevant cri-
teria. Their suggestions were then turned into 
quantitative values and the average of these 
values was chosen as the threshold. In the sec-
ond exercise, thresholds were derived post-
hoc, as the lowest 10% of the scores on any 
given criteria.
The concept of weights complements the 
concept of thresholds. The scoring performed 
by technical experts, which eventually leads to 
intermediate scores, is based on the assump-
tion that all criteria are mutually indepen-
dent and equally important (Figure 1). The 
concept of weights makes some intermediate 
scores more important than the others, which 
is determined by the stakeholders. In this way, 
their system of values is reflected in assign-
ing different weights to criteria used for pri-
ority setting before the final priority score is 
computed for each research option. Numeri-
cal values for these weights can be obtained 
through survey conducted among the appro-
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priate group of representatives of the stake-
holders (termed “larger reference group” – 
LRG).
Design of questionnaires used to assess 
stakeholders’ values
We tested three different versions of question-
naires (Table 1). The simplest version had five 
simple questions that captured the essence of 
each of the criteria relevant to priority setting 
that were highlighted by CHNRI’s previous 
work on conceptual framework for the meth-
odology (9-11). The questions were short and 
they used layman’s terms. The intermediate 
version of the questionnaire (Table 1) listed 
some technical terms that described each of 
the five criteria relevant to priority setting (9-
11). These terms required some understand-
ing of public health concepts and they were 
therefore used in a smaller group of stakehold-
ers’ representatives. Finally, the most complex 
version was tested in a relatively small group 
of highly motivated people with good un-
derstanding of the issues related to health re-
search investments, aiming to obtain deeper 
understanding of the elicited weights.
In the simplest version of the question-
naire, output from stakeholders’ representa-
tives were simple ranks of the five listed crite-
ria in ascending order, with the first indicating 
the most important criterion (ranks ranged 
from 1 to 5). An average of the individually 
suggested rank for each of the five criteria was 
computed. Then, if all five criteria were valued 
exactly the same, their average rank would be 
3.0. Therefore, any increase from this expect-
ed value toward the theoretical maximum of 
5.0 indicated lower assigned importance to the 
criterion, while any decrease toward the theo-
retical minimum of 1.0 indicated greater as-
signed importance. Dividing the expected av-
erage rank (3.0) by the observed (ie, obtained) 
average rank gave us numerical weights for the 
five criteria. These weights can theoretically 
range between 3.0 (which is the expected av-
erage rank of 3.0 divided by theoretically most 
favorable average rank of 1.0) and 0.6 (which 
is the expected average rank of 3.0 divided by 
theoretically the least favorable average rank 
of 5.0). In this way, intermediate scores for 
the criteria that were seen as more important 
by stakeholders’ representatives were assigned 
greater weight (of up to 3 times), while the 
weight of the criteria that were considered less 
important by the LRG could be reduced in 
importance (up to 40% reduction).
In the other two versions of the question-
naire, stakeholders’ representatives were asked 
to allocate US $100 (this amount was set ar-
bitrarily because it is intuitive) across the five 
Figure 1. Graphical presentation of the concept of thresholds and weights (T1-Tn and W1-Wn). A priority-setting tool above addresses n key priority 
setting criteria (eg, answerability, effectiveness, deliverability, maximum potential for disease burden reduction, and impact on equity); intermediate 
scores for this particular research options had values IS1-ISn. Input from stakeholders resulted in values W1-Wn, ie, factors by which each criterion’s 
value (intermediate score) is weighted, and threshold scores (T1-Tn) needed to be met within each criterion in order for the proposed research op-
tion to be considered a priority. The final “research priority score” (RPS) for each proposed research avenue is defined as their weighted average: 
[W1 × (Criterion 1 score) + W2 × (Criterion 2 score) + … + Wn x (Criterion n score)] / (W1+…+Wn)
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criteria. The amount allocated to each criteri-
on reflected its relative importance to stake-
holders. Eventually, every criterion then had 
its average “value” expressed in US$. All inter-
mediate scores could then be multiplied with 
average value of weights (in US$), added up 
and then divided by US $100. This gave the fi-
nal research priority score, which again had a 
value between 0 and 100.
Composition of larger reference group of 
stakeholders’ representatives
The CHNRI methodology proposes that the 
process of setting priorities in health research 
investments should involve two main groups: 
1) technical working group (TWG), which 
consists of technical experts (mainly scien-
tists) who assign a value (the intermediate 
score) to each proposed health research op-
tion by judging its likelihood to address each 
of the criteria relevant to priority setting; 2) 
larger reference group (LRG), which should 
comprise representatives of all other stake-
holders not represented in the TWG. The 
initiators of the priority setting process (eg, 
funding agencies, national governments, in-
ternational agencies) should be responsible 
for gathering this larger reference group of 
Table 1. Three versions of questionnaire that can be presented to larger reference group of stake holders, depending on the size and 
background of larger reference group membership and the desired level of complexity and amount of information that needs to be 
captured
Versions
Version 1 (the simplest form)
Please assign relative importance to the following 5 criteria:*
That the new or improved health intervention is likely to indeed be developed through proposed research investment
That, if developed, it is likely to have a real and true effect against the disease that it aims to tackle
That, if developed, it is likely to be delivered to most of those who are in need for it
That, if developed, it has a potential to make substantial share of the disease cases disappear
That, if developed, it is likely to become available to all segments of the society equally
Version 2 (intermediate complexity)
Please assign relative importance to the following 5 criteria:*
Answerability and ethics
Efficacy and effectiveness
Deliverability, affordability and sustainability
Maximum potential for disease burden reduction
Equity in achieved disease burden reduction
Version 3 (the most complex)
Please assign relative importance to the following 5 criteria:*
The proposed research questions will be answerable in an ethical way:
(Please explain further the relative importance of answerability and ethics to each other within this criterion)
Answerability: the research is likely to lead to discovery of new knowledge
Ethics: the research would achieve its aims in an ethical way
The proposed research will create new knowledge that would increase the efficacy and effectiveness of child health and nutrition interventions
(Please explain further the relative importance of efficacy and effectiveness to each other within this criterion)
Efficacy: The research would yield information on impact of the intervention on disease/disability in child health and nutrition under ideal 
conditions, such as the randomized controlled trials
Effectiveness: The research would yield information on impact of the intervention on disease/disability in child health and nutrition when 
implemented in the real world context
The proposed research will create new knowledge that would improve deliverability, affordability and sustainability of child health and nutrition 
interventions in the given context
(Please explain further the relative importance of deliverability, affordability and sustainability to each other within this criterion)
Deliverability: The intervention based on proposed research will be deliverable (infrastructure: basic intervention design, communication and 
transport infrastructure, need for human resources) in the context
Affordability: The intervention based on proposed research will be affordable (available resources in place to implement the intervention) in the 
context
Sustainability: The intervention based on proposed research will be sustainable (government capacity and partnership requirements, ease of 
delivery and usage characteristics) in the given context
The proposed research will lead to new knowledge that would expand the magnitude of impact of child health and nutrition interventions on human 
potential through the reduction of mortality, disease and promotion of mental, physical and cognitive development
The proposed research will lead to new knowledge that would improve child health and nutrition interventions in a way that they would become more
likely to benefit the most vulnerable populations (eg, the poor, visible minorities, children of female headed house holds, orphans) in the given context
*The way this particular question is phrased will depend on the way in which their responses would afterwards be turned into numerical weights; this question could be posed either 
as asking larger reference group (LRG) members to rank the 5 criteria from first to fifth in order of importance, or to distribute US $100 by those 5 criteria respecting their relative 
importance.
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stakeholders bearing in mind the aim of the 
exercise and general context.
In our article, where the context was de-
fined as global health research and relevant 
policies were already set by United Nation’s 
(UN) Millennium Development Goals (15), 
we used three different groups of stakeholders’ 
representatives – all of whom were particular-
ly suitable to administration of the respective 
version of the questionnaire. This composition 
is presented in detail in the examples given be-
low in the results section and further discussed 
in the discussion section of this paper.
Results
Exercise 1: Internet-based survey of the affiliates 
to the Global research priority setting network
Between March and May 2006, 30 affiliates to 
the Global Priority Setting Research Network 
agreed to participate in a piloting test and to 
represent the reference group of stakeholders 
for global childhood mortality issues (address-
ing the UN’s Millennium Development Goal 
4). Respondents included researchers, policy-
makers, and health practitioners with inter-
est in the field of priority setting in health care 
from high, low, and middle income countries. 
They were sent the simplest form of the ques-
tionnaire (Table 1, version 1) and asked to 
simply rank the criteria from 1st to 5th by the 
order of their importance and to return their 
ranks. They were also asked to set thresholds 
on each of the five criteria (Table 2).
The respondents placed the greatest weight 
(1.75) to maximum potential for disease bur-
den reduction, while the weights for the re-
maining four criteria were similar to each oth-
er and smaller than 1.00. The highest threshold 
was placed on the criterion of answerability in 
an ethical way (54/100), while the lowest was 
placed on maximum potential for disease bur-
den reduction (39/100) (Table 2).
Exercise 2: Interview-type survey in identified 
group of stakeholders in South Africa
This example differs from the first and third 
one because it refers to the exercise conduct-
ed at the national level, rather than global 
one (11). It is presented here to demonstrate 
how, when recruiting larger reference group of 
stakeholders’ representatives, context can be of 
particular importance. In South Africa, given 
its apartheid history and the history of health 
systems organization and management, when 
identifying participants in the larger refer-
ence group it was very important to recognize 
the ideological environment within which the 
Table 2. Suggested weights and thresholds by the representatives of the stakeholders
Version of the questionnaire Mean rank (1-5) Mean suggested weight Mean suggested threshold
Simple version of the questionnaire:*
 question related to answerability and ethics 3.14 0.96 54/100
 question related to efficacy and effectiveness 3.50 0.86 47/100
 question related to deliverability, affordability and sustainability 3.36 0.89 42/100
 question related to potential for disease burden reduction 1.71 1.75 39/100
 question related to predicted impact on equity 3.29 0.91 41/100
Intermediate version of the questionnaire:
 answerability and ethics 3.72 0.80 bottom 10%
 efficacy and effectiveness 2.75 1.09 bottom 10%
 deliverability, affordability and sustainability 2.94 1.02 bottom 10%
 maximum potential for disease burden reduction 3.28 0.91 bottom 10%
 predicted impact on equity 2.31 1.30 bottom 10%
Complex version of the questionnaire:
 efficacy and effectiveness US $19.20 0.192 NA†
 deliverability, affordability and sustainability US $32.89 0.329 NA
 maximum potential for disease burden reduction US $24.21 0.242 NA
 predicted impact on equity US $23.94 0.239 NA
*The simple version of the questionnaire was used to survey the members of the global research priority setting network; the intermediate version for a diverse group of national-level 
stakeholders from South Africa; and the most complex one to the participants at the conference related to international child health held in Washington, DC, USA
†NA – not applicable.
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study was being conducted. While gender and 
wealth inequities were central, equity in this 
context also referred to attempts to redress the 
racial determination of access to health care 
and services.
In May 2006, LRG members were recruit-
ed. Participants were identified using different 
strategies and included: 1) participants at a lo-
cal public health conference; 2) academicians 
(from disciplines ranging from history to psy-
chology and public health) from the three uni-
versities in the Western Cape Province and 
one from the University of Kwazulu-Natal; 
3) workers at the Medical Research Council 
and the Human Sciences Research Council in 
Cape Town; 4) “lay people,” including child 
and youth care workers, teachers, social work-
ers, a statistician, a health journalist; and 5) 
members of the public. Detailed description 
of this group of stakeholders’ representatives 
was presented by Tomlinson et al (11). These 
stakeholders used the version of the question-
naire of intermediate complexity (Table 1, ver-
sion 2).
Predictably, the greatest weight in this spe-
cific context was placed upon the criterion 
“predicted impact on equity” (1.30), while the 
weights for the remaining four criteria were 
similar to each other and close to 1.00 (Table 
2). It was decided that thresholds should not 
be determined in the same way as in the first 
exercise, but rather by excluding all research 
options that found themselves in bottom 10% 
for any of the five criteria (Table 2).
Exercise 3: Interview-type survey at the 
international conference on child health
In June 2006, the most complex version of the 
questionnaire (Table 1, version 3) was admin-
istered by trained university students to 20 
participants at the conference related to in-
ternational child health held in Washington, 
DC, USA. Respondents included mostly fe-
male program implementers with a couple of 
students, researchers, and fundraisers. Respon-
dents were also asked to evaluate the process 
and suggest any other important criteria that 
may not have been included in the question-
naire. In this exercise, they were asked to al-
locate US $100 to the presented criteria and 
sub-criteria deemed as relevant to health re-
search priority setting.
Three respondents allocated 0 dollars to cri-
terion 2 (efficacy and effectiveness), criterion 4 
(maximum potential for disease burden reduc-
tion) and criterion 5 (predicted impact on eq-
uity) (Table 2). One respondent allocated all 
US $100 to criterion 4. When the average allo-
cations were computed, the highest allocation 
(US $ 32.89) went to criterion 3 (deliverabil-
ity, affordability, sustainability) and the small-
est allocation (US $19.20) went to criterion 2 
(efficacy and effectiveness). Criteria 4 and 5 re-
ceived almost the same allocation (US $24.21 
and US $23.94, respectively). Respondents 
proposed some additional criteria including 
popular/political support, government com-
mitment, and cultural acceptability (which cri-
teria may be included in the criterion of deliv-
erability and sustainability, Table 2).
Discussion
This article presents a strategy of involving a 
variety of stakeholders who lack technical ex-
pertise into decision-making process on in-
vestments into health research. The process of 
research priority setting is clearly complex and 
multi-dimensional and it should be perceived as 
legitimate and fair by those affected by the de-
cisions (1). CHNRI recently presented a new 
systematic methodology for setting priorities 
in health research investments that highlighted 
five different broad and mutually independent 
dimensions (“lenses”) through which compet-
ing research options could be viewed as pri-
orities over each other (Figure 1) (8-10). The 
methodology takes into account all those cri-
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teria when assigning a value to each proposed 
research option, and it can flexibly introduce 
more criteria or leave some of the proposed 
ones out. Each research option is scored against 
each of the criteria to derive intermediate scores 
that transparently highlight its strengths and 
weaknesses (8). Those intermediate scores are 
initially determined by people with technical 
expertise, but then subjected to thresholds and 
weights set by a large group of stakeholders. The 
thresholds and weights reflect stakeholders’ 
own systems of values and their definition does 
not require technical expertise.
Delegating the representatives of stake-
holders into the larger reference group should 
involve systematic listing of the different 
groups of the relevant stakeholders. These 
may include research funding agencies, di-
rect recipients of research funds, beneficia-
ries of the research, and any other group with 
interest in prioritization process (16). When 
convening this group, there should be clear 
agreement upon the rationale and the rela-
tive importance of each stakeholder group. 
The relative importance may be reflected in 
either the group’s sample size or the weight 
put on their responses relative to the others’. 
The actual size and composition of the group 
would depend on the research options to be 
considered and the available resources includ-
ing time. Stakeholders can be represented by a 
reasonably small or very large reference group, 
depending on the context. For example, the 
group may comprise of only 10 persons (eg, 
main individual donors to a private chari-
ty who want to participate in decision-mak-
ing on how their money is invested) or more 
than a thousand people (eg, in the case of ad-
dressing research to avert global child mortali-
ty, where everyone from members of public in 
developing countries, public and private do-
nor foundations, to the UN, World Health 
Organization (WHO) and UNICEF officials 
represent the potential stakeholders).
Small reference group of stakeholders is 
appropriate when several major donors to any 
health research-funding organization want to 
influence priority setting process. They can set 
very specific thresholds and weights for each 
criterion. Large and diverse reference group of 
stakeholders is more appropriate for priority 
setting for health research on problems of re-
gional or global importance. In the latter case, 
the size and diversity of the representatives of 
stakeholders may lead to regression of thresh-
olds to the mean, regardless of the criteria. In 
this case a different approach is proposed, by 
setting a threshold at bottom 10% or 20% of 
values of all scored research options for any 
of the criteria. In this way, stakeholders will 
set the overall level of tolerance toward un-
derachieving in any single criterion. They may 
even set such percentile-based thresholds for 
each criterion individually (Figure 1).
It should be stressed that intermediate 
scores upon which weights and thresholds are 
placed do not exactly represent likelihood that 
the research option would fulfill the criterion 
in question. They are abstract numbers that 
measure collective optimism of technical ex-
perts about that likelihood. Therefore, when 
thresholds are being set by larger reference 
group of stakeholders as specific cut-off points 
on a scale 0-100, it may be very difficult to pre-
dict them intuitively. In all such cases, we ad-
vise that those who set thresholds should be 
made aware of the distribution of the values 
of intermediate scores, without linking these 
values to specific research options. In this way, 
more useful thresholds can be suggested. Oth-
erwise, it is likely that some thresholds may 
not disqualify any option, and therefore be re-
dundant, or may disqualify unreasonable pro-
portion of scored research options. In our 
first exercise, it became apparent that thresh-
olds cannot be set in advance intuitively, given 
the reasons above. In our second exercise we 
felt that it would be more appropriate to un-
Croat Med J 2007;48:618-627
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derstand the outcome first, and then set these 
thresholds post hoc, so we applied the statisti-
cal approach based on lowest 10%. In the third 
exercise we dropped the thresholds altogether, 
although the statistical approach from the sec-
ond exercise could still be applied.
The first version of the questionnaire test-
ed in this article is highly recommended for use 
in very large reference groups, involving repre-
sentatives from different backgrounds and lev-
els of education. The second (intermediate) 
version may not be suitable for some mem-
bers of the larger reference group of stakehold-
ers, some of whom may lack the appropriate 
background or literacy levels to clearly under-
stand the proposed concepts. However, if a 
survey involves people with the appropriate 
knowledge, our view is that this questionnaire 
should be more useful. This is because the ques-
tions in the second version correlate more di-
rectly to the chosen criteria for priority setting, 
whereas in the first version they were translat-
ed into layman’s terms, but in this simplifica-
tion there is always a concern that the essence 
of the criterion was slightly distorted and that 
the stakeholders are not understanding all the 
questions in the same way. Finally, the most 
complex form of the questionnaire should only 
be used in exceptional cases such as: 1) when 
the larger reference group is formed by a rela-
tively small number of highly motivated people 
with a good understanding of the issues related 
to health research investments, 2) for the pur-
pose of qualitative research on the stakehold-
ers’ values where this form of questionnaire 
could provide more detailed information, pro-
viding a deeper understanding of the elicited 
weights. In our exercise, the first group was an 
experimental group and they had no modera-
tor to their exercise, so we needed to keep the 
questionnaire as simple as possible and present-
ed them with the simplest form. In the second 
group, members of the public formed a mi-
nority of the group (up to 10%) and they were 
moderated through the exercise, so they were 
able to join the survey although it was a more 
demanding one. In the third group, the back-
ground of the stakeholder groups justified the 
use of the most complex form.
When turning the input from the stake-
holders into useful quantitative values, the 
first version of the questionnaire was the sim-
plest and it worked very well in practice. Still, 
it should be recognized that it has conceptu-
al shortcomings. There is no clear theoretical 
justification for limiting the weights for inter-
mediate scores to values between 0.6 and 3.0. 
In view of this limitation, we recommend the 
second approach (distribution of US $100) 
wherever possible. This approach places no 
limits on the values of the weights. In extreme 
cases, some criteria (intermediate scores) may 
be assigned an average weight of zero by the 
larger reference group of stakeholders and 
thereby be excluded from influencing the fi-
nal priority score.
Some important lessons were also learned 
through interviewing stakeholders’ repre-
sentatives in different contexts. In South 
Africa, where stakeholders were gathered 
from within national boundaries, equity was 
ranked higher than some of the most popu-
lar criteria in similar contexts (7,17). This 
underscores the importance of eliciting lo-
cal values (18,19). Given the variations in in-
dividual values in this context, technical ex-
perts who were deriving intermediate scores 
recommended that the choice of representa-
tives of the stakeholders should be systemat-
ic to ensure representation from all relevant 
stakeholders (11). The feedback from stake-
holders’ representatives attending large in-
ternational health conference in Washing-
ton, USA, where the most complex form of 
the questionnaire was administered, included 
comments that the interview should be guid-
ed by trained research assistants. Suggestions 
were made to delineate the criteria especially 
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in contexts where the individual criteria may 
be valued differently. Finally, since the five 
proposed criteria were not exhaustive, there 
should always be provision for respondents to 
give suggestions for criteria that may be rele-
vant to their local context.
In conclusion, this article addressed one 
of the most pressing issues in health research 
priority setting globally – the lack of involve-
ment of stakeholders other than the scientists 
in decision-making process on investments. 
This article presents how this can be achieved 
through introducing a large reference group 
of stakeholders’ representatives that comple-
ment the work of technical experts. The rep-
resentatives of stakeholders are enabled to 
assign greater value to some of the priority-
setting criteria defined by technical experts. 
This adds a dimension of public opinion to 
the rational scientific assessment of the re-
search options derived by technical experts. 
Thresholds and weights set in this way are 
transparent and can be later challenged or re-
vised based on a feedback. The change may be 
prompted by the outcomes of priority setting 
process or because of the changes in dynamic 
social, political, or economic context. While 
this paper provides some progress in includ-
ing stakeholders’ values in decision making, 
there are still unresolved problems of how 
the proposals put forward can be operation-
alized in the real world (20). Future work 
should focus on these areas.
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